中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2012年
11期
2148-2149
,共2页
陆树洋%孙晓宁%洪涛%宋凯%杨守国%王春生
陸樹洋%孫曉寧%洪濤%宋凱%楊守國%王春生
륙수양%손효저%홍도%송개%양수국%왕춘생
主动脉%血管平滑肌细胞%培养
主動脈%血管平滑肌細胞%培養
주동맥%혈관평활기세포%배양
Aorta%Vascular smooth muscle cells%Cell culture
目的 建立成人主动脉血管平滑肌细胞体外培养的有效方法.方法 无菌条件下分离成人主动脉的平滑肌层,剪成1 mm3的碎片,0.1% Ⅰ型胶原酶预处理1h,组织块贴壁法,以含胎牛血清20%的DMEM低糖培养基培养.倒置显微镜观察培养细胞的形态学特点,免疫荧光法检测平滑肌细胞肌动蛋白(α-SMA)的表达.结果 培养至4~5d组织块边缘即有少量细胞爬出,呈长梭形,胞质丰富;培养至1~2周组织块边缘细胞融合,呈典型的“峰谷”样表现.免疫荧光染色结果显示胞质内α-SMA的表达丰富,荧光强度在(++)~ (+++).结论 胶原酶预处理组织的改良组织块贴壁法培养人主动脉血管平滑肌细胞是一种可行有效的实验方法.
目的 建立成人主動脈血管平滑肌細胞體外培養的有效方法.方法 無菌條件下分離成人主動脈的平滑肌層,剪成1 mm3的碎片,0.1% Ⅰ型膠原酶預處理1h,組織塊貼壁法,以含胎牛血清20%的DMEM低糖培養基培養.倒置顯微鏡觀察培養細胞的形態學特點,免疫熒光法檢測平滑肌細胞肌動蛋白(α-SMA)的錶達.結果 培養至4~5d組織塊邊緣即有少量細胞爬齣,呈長梭形,胞質豐富;培養至1~2週組織塊邊緣細胞融閤,呈典型的“峰穀”樣錶現.免疫熒光染色結果顯示胞質內α-SMA的錶達豐富,熒光彊度在(++)~ (+++).結論 膠原酶預處理組織的改良組織塊貼壁法培養人主動脈血管平滑肌細胞是一種可行有效的實驗方法.
목적 건립성인주동맥혈관평활기세포체외배양적유효방법.방법 무균조건하분리성인주동맥적평활기층,전성1 mm3적쇄편,0.1% Ⅰ형효원매예처리1h,조직괴첩벽법,이함태우혈청20%적DMEM저당배양기배양.도치현미경관찰배양세포적형태학특점,면역형광법검측평활기세포기동단백(α-SMA)적표체.결과 배양지4~5d조직괴변연즉유소량세포파출,정장사형,포질봉부;배양지1~2주조직괴변연세포융합,정전형적“봉곡”양표현.면역형광염색결과현시포질내α-SMA적표체봉부,형광강도재(++)~ (+++).결론 효원매예처리조직적개량조직괴첩벽법배양인주동맥혈관평활기세포시일충가행유효적실험방법.
Objective To establish an effective method of human vascular smooth muscle cells in vitro culture.Methods Medial layer of human aorta was separated under sterile conditions,then cut into small pieces (about 1 mm3).After pretreatment with 0.1% type Ⅰ collagenase,the tissues were transferred into flask and cultured in DMEM containing 20% fetal bovine serum,penicillin (100 U/ml) and streptomycin (100 g/L).The cell morphology was observed under the inverted microscopy.Smooth muscle cell specific protein (α-SMA) was identified by using immumofluorescence methods.Results Some smooth muscle cells started growing from explants in 4 to 5 days.One to 2 weeks later,the cells grew to confluence by migrated cells.Immumofluorescence staining showed positive expression of α-SMA (fluorescence intensity (++)-(+++)).Conclusion Modified explant technique by pretreating tissues with collagenase was an effective method to get vascular smooth muscle cells in vitro.